General Information
DRAVP ID DRAVPe00539
Peptide Name peptide 22
Sequence LQQLAFIHFRIGRRRRRRRR
Sequence Length 20
UniProt ID No entry found
Taxon ID None
Source Synthetic construct
Validation Experimentally Validated
Origin Information
Gene Name/ID Not Available
GenBank Not Available
Amino Acid position Not Available
Domain Accession ID Not Available
Nucleotide sequence ID Not Available
Molecular Type Not Available
Chromosomal Position Not Available
Activity Information
Target Organism HIV
Assay Integrase assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target Integrase
Mechanism The peptide acts antiviral activity by inhibiting the activity of integrase.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe00539
Linear/Cyclic Linear
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C117H203N51O23
Absent amino acids CDEKMNPSTVWY
Common amino acids R
Mass 2692.23
Pl 12.9
Basic residues 10
Acidic residues 0
Hydrophobic residues 7
Net charge 10
Boman Index -12163
Hydrophobicity -135.5
Aliphatic Index 83
Half Life
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Literature Information
Literature 1
Title Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.
Pubmed ID 20708407
Reference Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.
Author Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H.